Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Reserpine Analogues

Abstract

IT seems likely that the most interesting pharmacological properties of the natural alkaloid reserpine are mainly determined by three chemical groups in the molecule : (1) the β-indolylethylamine group, which is present in many other natural drugs (serotonine, ergot alkaloids) ; (2) a tertiary nitrogen atom which is substituted by three carbon chains, one of which (the ethyl group) is attached to the indole nucleus, while the other two form part of a ring system bearing (3) a hydroxyl group which is esterified by trimethoxybenzoic acid. The β-phenylethylamine group, which is very similar to the β-indolylethylamine group, is found in another group of drugs, the adrenaline family.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

KRALT, T., MOED, H., CLAASSEN, V. et al. Reserpine Analogues. Nature 188, 1108–1109 (1960). https://doi.org/10.1038/1881108b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/1881108b0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing